The board also authorized execution of the purchase agreement and related documents, and is submitting the deal for stockholder approval by written consent.
Board approves sale of Lifeline Cell Technology
International Stem Cell’s board, acting by unanimous written consent on July 10, 2026, cleared a sale of its Lifeline Cell Technology unit.
The transaction calls for selling 100% of Lifeline Cell Technology membership interests to ATCC for USD 25 million, subject to working-capital, cash, and debt adjustments.
ATCC is to pay cash at closing, withholding USD 2.5 million for an indemnity escrow and USD 100,000 for an adjustment escrow.
ISCO•
